[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559429":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":7,"responsibleParty":20,"collaborators":7,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":26,"acronym":27,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":7,"enrollmentInfo":31,"targetDuration":7,"studyType":34,"phases":7,"briefSummary":35,"conditions":36,"keywords":42,"overallStatus":48,"whyStopped":7,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":7},{"fullName":5,"class":6},"Sunnybrook Health Sciences Centre","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Christopher Cheung, MD","Sunnybrook Hospital","PRINCIPAL_INVESTIGATOR",[14],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Aditi Garg, MA","CONTACT","5196612111","86013","aditi.garg@lhsc.on.ca",{"type":21,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100559429","wearable-cardiac-monitor-to-enhance-detection-of-arrhythmia-recurrence-after-catheter-ablation-of-atrial-fibrillation-100559429",false,"NCT06564012","Wearable Cardiac Monitor to Enhance Detection of Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation","WEAR-AF","Inclusion Criteria:\n\n* Adults aged 18 years or older.\n* Diagnosed with paroxysmal or persistent atrial fibrillation.\n* Scheduled to undergo catheter ablation for atrial fibrillation.\n* Able to provide informed consent.\n* Willing to wear the Skiin garments (chest band or bralette) for the duration of the study (approximately 1 month pre and 6 months post-ablation).\n* Have a smartphone with an Operating System compatible with the Skiin Connected Life App (Android 9+ or iOS 13+)\n\nExclusion Criteria:\n\n* Adverse reaction to Skiin garments (e.g. skin allergy)\n\nThe relevant Skiin Underwear contraindications acting as exclusion criteria for this study are:\n\n* Pacemaker and\u002For (ICD) implantable cardioverter defibrillator users.\n* Pregnancy","ALL","18 Years",{"count":32,"type":33},100,"ESTIMATED","OBSERVATIONAL","The WEAR-AF study is a prospective, multicenter clinical trial designed to evaluate the efficacy of wearable technology in the detection, monitoring, and management of atrial fibrillation (AF). This study aims to assess how wearable devices, such as smartwatches equipped with electrocardiogram (ECG) capabilities, can be used to identify AF episodes, guide treatment decisions, and ultimately improve patient outcomes.\n\nParticipants will be individuals diagnosed with or at high risk for atrial fibrillation. The study will track the accuracy of AF detection, patient adherence to monitoring, and the impact on clinical outcomes, including stroke prevention, symptom management, and quality of life.\n\nThe findings from WEAR-AF are expected to contribute to the growing body of evidence supporting the integration of wearable technology into routine clinical practice for AF management, offering insights into its potential to enhance patient care and reduce healthcare costs.",[37,38,39,40,41],"Atrial Fibrillation","Arrhythmias, Cardiac","Heart Diseases","Cardiovascular Diseases","Stroke Prevention",[43,44,45,46,47],"digital health","wearable technology","electrocardiography","remote monitoring","patient adherence","NOT_YET_RECRUITING","2025-05-20",{"date":51,"type":52},"2025-05-25","ACTUAL",{"date":54,"type":33},"2025-07-01",{"date":56,"type":33},"2026-12",{"name":5,"class":6}]